|
顯示項目 430946-430970 / 2348419 (共93937頁)
<< < 17233 17234 17235 17236 17237 17238 17239 17240 17241 17242 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
1998 |
First, Second, and Third: An Epistemological Reflection on Comparative Methodology through Reviewing Tim-hung Ku 古添洪, Jihao Shixue 記號詩學 [Semiotics of Poetry] and Karl H. Kao 高辛勇,Xingmingxue yu xushi lilun 形名學與敘事理論 [Semiotics and Narratology].”
|
李鴻瓊 |
| 國立臺灣大學 |
2008 |
First- and Second-Trim Ester down Syndrome Screening: Current Strategies and Clinical Guidelines
|
蕭勝文; 徐振傑; 李建南; 蕭慶華; 陳持平; 謝燦堂; 鄭博仁; SHAW, SHENG-WEN; HSU, JENN-J; LEE, CHIEN- NAN; HSIAO, CHING-HUA; CHEN, CHIH-PING; HSIEH, T'SANG-T'ANG; CHENG, PO-JEN |
| 臺大學術典藏 |
2018-09-10T07:14:00Z |
First- and second-trimester down syndrome screening: Current strategies and clinical guidelines
|
Shaw, S.-W. and Hsu, J.-J. and Lee, C.-N. and Hsiao, C.-H. and Chen, C.-P. and Hsieh, T.-T. and Cheng, P.-J.; 蕭勝文;徐振傑;李建南;蕭慶華;陳持平;謝燦堂;鄭博仁; SHAW, SHENG-WEN;HSU, JENN-J;LEE, CHIEN- NAN;HSIAO, CHING-HUA;CHEN, CHIH-PING;HSIEH, T'SANG-T'ANG;CHENG, PO-JEN; CHIEN-NAN LEE; SHAW, SHENG-WEN; HSU, JENN-J; LEE, CHIEN- NAN; HSIAO, CHING-HUA; CHEN, CHIH-PING; HSIEH, T'SANG-T'ANG; CHENG, PO-JEN |
| 臺大學術典藏 |
2020-02-12T04:06:09Z |
First- and second-trimester down syndrome screening: Current strategies and clinical guidelines
|
Cheng P.-J.;Hsieh T.-T;Chen C.-P;Hsiao C.-H;CHIEN-NAN LEE;Hsu J.-J;Shaw S.-W; Shaw S.-W; Hsu J.-J; CHIEN-NAN LEE; Hsiao C.-H; Chen C.-P; Hsieh T.-T; Cheng P.-J. |
| 義守大學 |
2014-05 |
First- and Third-Person Perceptions: Using the Ostensible Audience as a Comparison Anchor in the Processes of Downward and Upward Social Comparisons
|
Sue-Jen Lin |
| 臺大學術典藏 |
2018-09-10T06:51:20Z |
First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer
|
Wu, J.-Y. and Yu, C.-J. and Yang, C.-H. and Wu, S.-G. and Chiu, Y.-H. and Gow, C.-H. and Chang, Y.-C. and Hsu, Y.-C. and Wei, P.-F. and Shih, J.-Y. and Yang, P.-C.; YEUN-CHUNG CHANG; Chong-Jen Yu; PAN-CHYR YANG; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-05-26T09:27:21Z |
First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer
|
Yang P.-C.;Shih J.-Y;Wei P.-F;Hsu Y.-C;Chang Y.-C;Gow C.-H;Chiu Y.-H;Wu S.-G;Chih-Hsin Yang;Yu C.-J;Wu J.-Y; Wu J.-Y; Yu C.-J; CHIH-HSIN YANG; Wu S.-G; Chiu Y.-H; Gow C.-H; Chang Y.-C; Hsu Y.-C; Wei P.-F; Shih J.-Y; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:31Z |
First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer
|
Wu J.-Y.; Yu C.-J.; Yang C.-H.; SHANG-GIN WU; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:00Z |
First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer
|
Wu J.-Y.; Yu C.-J.; Yang P.-C.; JIN-YUAN SHIH; Wei P.-F.; Hsu Y.-C.; Chang Y.-C.; Gow C.-H.; Yang C.-H.; Wu S.-G.; Chiu Y.-H. |
| 臺大學術典藏 |
2020-12-02T02:34:31Z |
First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer
|
Wu J.-Y.; Yu C.-J.; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Pan-Chyr Yang; Wu J.-Y.; Yu C.-J.; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; PAN-CHYR YANG |
| 臺大學術典藏 |
2021-03-19T06:57:51Z |
First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer
|
Wu J.-Y.; Yu C.-J.; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; YEUN-CHUNG CHANG; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:07:54Z |
First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer
|
Wu J.-Y.; CHONG-JEN YU; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Yang P.-C. |
| 國立臺灣大學 |
2008-10 |
First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer.
|
Wu, Jenn-Yu; Yu, Chong-Jen; Chih-HsinYang; Wu, Shang-Gin; Chiu, Yueh-Hsia; Gow, Chien-Hung; Chang, Yeun-Chung; Hsu, Ya-Chieh; Wei, Pin-Fei; Shih, Jin-Yuan; Yang, Pan-Chyr |
| 慈濟大學 |
2012 |
First-attack pediatric hypertensive crisis presenting to the pediatric emergency department
|
Yang, Wen-Chieh;Zhao, Lu-Lu;Chen, Chun-Yu;Wu, Yung-Kang;Chang, Yu-Jun;Wu, Han-Ping |
| 淡江大學 |
2007-03 |
First-Best Tax Policy, Congestion, and Imperfect Competition
|
Hung, Hsiao-wen |
| 中原大學 |
2001 |
First-come-First-Served Polling Systems
|
Kuo-Hwa Chang |
| 國立交通大學 |
2019-04-03T06:40:15Z |
First-ever ischemic stroke in elderly patients: predictors of functional outcome following carotid artery stenting
|
Lin, Chih-Ming; Chang, Yu-Jun; Liu, Chi-Kuang; Yu, Cheng-Sheng; Lu, Henry Horng-Shing |
| 亞洲大學 |
2016-11 |
First-ever stroke following hip replacement surgeries: a large population-based survey.
|
Wang, Chia-To;Wang, Chia-To;Chuang, Eric;Chuang, Eric;Yen, Der-Jen;Yen, Der-Jen;Chu, Tien-Yow;Chuang, Tien-Yow;Mu, Chih-Hsin;Muo, Chih-Hsin;高嘉鴻;Kao, Chia-Hung;* |
| 淡江大學 |
2012-07-06 |
First-fit chromatic numbers of d-degenerate graphs
|
Chang, Gerard Jennhwa;Hsu, Hsiang-Chun |
| 國立臺灣大學 |
2012 |
First-generation college students' information seeking: Their personality traits and source use behavior in coursework-related context
|
TIEN-I TSAI; Tsai, T.-I. and Kim, K.-S. |
| 國立高雄師範大學 |
1998 |
First-grade children’s use of analogy in word reading
|
C. C. Wang;J. S. Gaffney |
| 國家衛生研究院 |
2021-08-12 |
First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients
|
Huang, JF;Dai, CY;Huang, CF;Tsai, PC;Yeh, ML;Hsu, PY;Huang, SF;Bair, MJ;Hou, NJ;Huang, CI;Liang, PC;Lin, YH;Wang, CW;Hsieh, MY;Chen, SC;Lin, ZY;Yu, ML;Chuang, WL |
| 國家衛生研究院 |
2024-01-29 |
First-in-class dual EZH2-HSP90 inhibitor eliciting striking antiglioblastoma activity in vitro and in vivo
|
Sharma, S;Wang, SA;Yang, WB;Lin, HY;Lai, MJ;Chen, HC;Kao, TY;Hsu, FL;Nepali, K;Hsu, TI;Liou, JP |
| 臺大學術典藏 |
2021-07-21T23:21:30Z |
First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma
|
Italiano, Antoine; Cassier, Philippe A.; Chia-Chi Lin; Alanko, Tuomo; Peltola, Katriina J.; Gazzah, Anas; Shiah, Her Shyong; Calvo, Emiliano; Cervantes, Andrés; Roda, Desamparados; Tosi, Diego; Gao, Bo; Millward, Michael; Warburton, Lydia; Tanner, Minna; Englert, Stefan; Lambert, Stacie; Parikh, Apurvasena; Afar, Daniel E.; Vosganian, Gregory; Moreno, Victor |
| 臺大學術典藏 |
2022-09-15T01:08:44Z |
First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma
|
Italiano A.; Cassier P.A.; Chia-Chi Lin; Alanko T.; Peltola K.J.; Gazzah A.; Shiah H.-S.; Calvo E.; Cervantes A.; Roda D.; Tosi D.; Gao B.; Millward M.; Warburton L.; Tanner M.; Englert S.; Lambert S.; Parikh A.; Afar D.E.; Vosganian G.; Moreno V. |
顯示項目 430946-430970 / 2348419 (共93937頁)
<< < 17233 17234 17235 17236 17237 17238 17239 17240 17241 17242 > >>
每頁顯示[10|25|50]項目
|
